Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The Cochrane Database of Systematic Reviews|October 8, 2019
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancerFelicia Roncolato, Kristina Lindemann, Melina L Willson, et al.Nurse Education Today|May 28, 2013
Distance and devices - potential barriers to use of wireless handheld devicesJulie Martyn, Kevin Larkin, Teresa Sander, et al.Nurse Education Today|May 28, 2013
Exploring the relationships between teaching, approaches to learning and critical thinking in a problem-based learning foundation nursing courseJulie Martyn, Ruth Terwijn, Megan Y C A Kek, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2011
The role of hormonal therapy in gynecological cancers-current status and future directionsKatrin M Sjoquist, Julie Martyn, Richard J Edmondson, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancerMichael Friedlander, Phyllis Butow, Martin Stockler, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2014
Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit studyMichael Leonard Friedlander, Martin Stockler, Rachel O'Connell, et al.Journal of Gynecologic Oncology|October 30, 2013
Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG studyPrunella Blinman, Corona Gainford, Mark Donoghoe, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2014
Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancerMadeleine T King, Martin R Stockler, Phyllis Butow, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 13, 2017
Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian CancerAnthony Bonaventura, Rachel L OʼConnell, Cristina Mapagu, et al.Pageof 1